N-Acetyltyramine
| Item number | Size | Datasheet | Manual | SDS | Delivery time | Quantity | Price |
|---|---|---|---|---|---|---|---|
| Cay9001373-5 | 5 mg | - |
6 - 10 business days* |
109.00€
|
|||
| Cay9001373-25 | 25 mg | - |
6 - 10 business days* |
373.00€
|
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
N-acetyltyramine is a metabolite of the biogenic amine tyramine (Cay-18601). It enhances... more
Product information "N-Acetyltyramine"
N-acetyltyramine is a metabolite of the biogenic amine tyramine (Cay-18601). It enhances cytotoxicity of doxorubicin (Cay-15007) in resistant P388 murine leukemia cells with an IC50 value of 0.13 µg/ml compared with an IC50 value of 0.48 µg/ml for doxorubicin alone.Formal Name: N-[2-(4-hydroxyphenyl)ethyl]-acetamide. CAS Number: 1202-66-0. Molecular Formula: C10H13NO2. Formula Weight: 179.2. Purity: >95%. Formulation: (Request formulation change), A solid. SMILES: OC1=CC=C(CCNC(C)=O)C=C1. InChi Code: InChI=1S/C10H13NO2/c1-8(12)11-7-6-9-2-4-10(13)5-3-9/h2-5,13H,6-7H2,1H3,(H,11,12). InChi Key: ATDWJOOPFDQZNK-UHFFFAOYSA-N.
| Keywords: | N-[2-(4-hydroxyphenyl)ethyl]-acetamide |
| Supplier: | Cayman Chemical |
| Supplier-Nr: | 9001373 |
Properties
| Application: | Doxorubicin cytotoxicity enhancer |
| MW: | 179.2 D |
| Formula: | C10H13NO2 |
| Purity: | >95% |
| Format: | Solid |
Database Information
| CAS : | 1202-66-0| Matching products |
Handling & Safety
| Storage: | -20°C |
| Shipping: | +20°C (International: -20°C) |
| Signal Word: | Danger |
| GHS Hazard Pictograms: |
|
| H Phrases: | H318 |
| P Phrases: | P280, P305+351+338, P310 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow.
more
You will get a certificate here
Viewed